Explore Xeris Biopharma Holdings stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XERS.

Xeris Biopharma Holdings Stock Price, Quotes and Forecasts | NASDAQ:XERS | Benzinga

Xeris Biopharma Holdings

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BFLY

LWAY

SKYH

SPNS

XERS

Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Penny stock: gli insider muovono il mercato con acquisti strategici

Long Ideas

Penny Stocks

Insider Trades

BCOV

PGEN

More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying

STKS

Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying

Xeris Biopharma Holdings, Inc. - Common Stock

Xeris Biopharma Holdings Inc

Press Releases

Xeris Biopharma Reports Third Quarter 2024 Financial Results

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

Xeris to Participate in Upcoming Investor Conferences

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

Arvinas

BGM Group

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cormedix

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Evolus

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

GH Research

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

Harrow

Indivior

Innoviva

Liquidia

Maze Therapeutics

Nuvation Bio

Ocular Therapeutix

Omeros

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Pacira BioSciences

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Tilray Brands

Trevi Therapeutics

Zevra Therapeutics

Leerink Partners

Craig-Hallum

Piper Sandler

HC Wainwright & Co.

Jefferies

Learn About Cryptocurrency

acf/sidebar-related-posts

Learn about this leading blockchain platform that supports decentralized applications and smart contracts.

What is Ethereum?

Earning interest on your Ethereum is a great way to grow your cryptocurrency holdings. Find out how to earn interest on your Ethereum in 4 easy steps.

How to Earn Interest on Ethereum

Discover the 10 best cryptocurrencies to invest in for January 2025. Stay ahead in the crypto market with our expert insights and analysis! Learn more now!

10 Best Cryptocurrencies to Invest In for March 2025

10 Best Cryptocurrencies to Invest in for January 2025

Discover the best altcoins to invest in for high potential returns. Our top altcoin picks include Ethereum, Solana, Ripple, Dogecoin, Toncoin.

Top 10 Best Altcoins • Benzinga Crypto

10 Best Altcoins in November 2024

Top Cryptocurrency News

acf/news-feed

Future Finance Newsletter

acf/page-sidebar-placement

Cryptocurrency /Money Sidebar

Application error: a client-side exception has occurred (see the browser console for more information).